Safety of Intermittent Parenteral Midazolam Injection in Hospitalized Patients Admitted to Non-Intensive Care Nursing Units: A Retrospective Matched-Cohort Study
The administration of parenteral midazolam in non-ICU nursing units resulted in a similar incidence of hypotension, bradycardia, bradypnea, escalation in oxygen requirement, and escalation in level of care compared with lorazepam. These results suggest that midazolam may have a similar safety profile to lorazepam, supporting its use in non-ICU nursing units.
Authors
- Richard R. Riker (ORCID: https://orcid.org/0000-0002-0682-6204)
- David Gagnon (ORCID: https://orcid.org/0000-0002-6367-3179)
- Nicolette Centanni (ORCID: https://orcid.org/0000-0003-1946-2849)
- Haley Torr
- Ashley Gale
- Maria M. Mills
Institutions
- Tufts University (US)
- Maine Medical Center (US)
- MaineHealth (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1177/10600280241299059
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00